MOLECULAR MECHANISMS OF MONOCYTE CHEMOTAXIS
单核细胞趋化性的分子机制
基本信息
- 批准号:2392766
- 负责人:
- 金额:$ 21.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-04-01 至 1999-03-31
- 项目状态:已结题
- 来源:
- 关键词:3T3 cells CD antigens Cryptococcus neoformans cellular immunity chemotaxis complement receptor cryptococcosis cytokine flow cytometry genetically modified animals glycosylation glycosylphosphatidylinositols immunoelectron microscopy inflammation laboratory mouse lectin leukocyte adhesion molecules mannose microorganism immunology monocyte phospholipase D plasminogen activator thin layer chromatography transfection
项目摘要
Mononuclear phagocytes are recruited to sites of pulmonary inflammation.
These sites can be associated with infectious, fibrosing and granulomatous
lung diseases. Recruitment is accomplished by directed migration
(chemotaxis). CD87 (the urokinase plasminogen activator (uPA) receptor) is
required for mononuclear phagocyte chemotaxis. The central hypothesis of
this proposal is that the essential role CD87 plays in mononuclear
phagocyte chemotaxis is dependent upon its expression, its localization to
specific plasma membrane micro-domains called caveolae, and its sequential
interaction with signaling proteins and other cell surface receptors. The
overall objective of this proposal is to delineate the mechanism by which
CD87 mediates mononuclear phagocytes chemotaxis. Our specific objectives
are: l) Determine a) whether aggregation of CD87 within caveolae is
required, and b) determine whether caveolin, the protein lining caveolae,
participates in signal transduction in during chemotaxis. 2) Determine
whether CD87 associates with complement receptor 3 (CR3) via carbohydrate-
lectin interactions to effect chemotaxis. 3) Determine if a
glycosylphosphatidylinositol-specific phospholipase D (GPI-PLD) mediated
mechanism contributes importantly to CD87 shedding. 4) Using transgenic
uPA deficient mice, determine if binding of uPA participates importantly
in CD87 function during chemotaxis in vitro, and cellular recruitment in
response to pulmonary inflammation induced by C. neoformans infection in
vivo. l) Visual localization of CD87 to caveolae and colocalization of
CD87 and caveolin will be accomplished by immunolabeling and electron
microscopy and immunofluorescent quantitative confocal microscopy.
Physical binding of CD87 and caveolin will be assessed by
immunoprecipitation and Western blotting. Signal transduction via caveolin
will be assessed by immunoprecipitation and Western blotting with anti-
phosphorotyrosine antibodies. 2) Carbohydrate-lectin interactions between
CD87 and CR3 will be assessed by colocalization studies in the presence
and absence of specific saccharides. Studies evaluating chemotaxis will be
done in parallel. Direct interaction between CR3 and CD87 and the specific
relevant domains of CD87 will be assessed using murine cells transfected
with CR3 and soluble human recombinant CD87. 3) PMA-and cytokine-induced
CD87 shedding will quantitated by ELISA and the mechanism determined by
analysis of the molecular weight of shed CD87 compared with known CD87
variants. Specific inhibitors of candidate mechanisms will be used to
assess the relative contribution of each to agonist-specific CD87
shedding. 4) Using uPA deficient mice, we will determine whether uPA plays
a role in mononuclear phagocytes chemotaxis in vitro, or in leukocyte
recruitment in response to pulmonary C. neoformans infection in vivo.
These studies will elucidate the molecular mechanism of CD87 dependent
mononuclear phagocyte chemotaxis. Through this knowledge, specific
therapeutic interventions may be developed to control and modulate
inflammatory responses.
单核巨噬细胞被招募到肺部炎症部位。
这些部位可能与感染性、纤维化性和肉芽肿有关。
肺部疾病。招聘是通过定向迁移完成的
(趋化性)。CD87(尿激酶型纤溶酶原激活物(UPA)受体)
单核巨噬细胞趋化所必需的。的中心假说
这一建议是CD87在单核细胞中所起的关键作用
吞噬细胞的趋化作用依赖于其表达,其定位于
称为小凹的特定质膜微区及其序列
与信号蛋白和其他细胞表面受体的相互作用。这个
这项提案的总体目标是勾勒出
CD87介导单核巨噬细胞趋化作用。我们的具体目标
L)确定a)CD87在小窝内的聚集是否
必需的,以及b)确定小窝,小窝的蛋白质衬里,
参与趋化过程中的信号转导。2)确定
CD87是否通过碳水化合物与补体受体3(CR3)结合
凝集素相互作用影响趋化作用。3)确定是否存在
糖基磷脂酰肌醇特异性磷脂酶D(GPI-PLD)介导
机制对CD87的脱落起重要作用。4)使用转基因技术
UPA缺陷小鼠,确定uPA结合是否重要参与
CD87在体外趋化和细胞募集中的作用
肺炎克雷伯氏菌感染引起的肺部炎症反应
活着。L)CD87在小窝的可视定位和共定位
CD87和小窝蛋白将通过免疫标记和电子技术完成
显微镜和免疫荧光定量共聚焦显微镜。
CD87和小窝的物理结合将通过以下方式进行评估
免疫沉淀和免疫印迹。小窝蛋白介导的信号转导
将通过免疫沉淀和Western blotting与抗
磷酸酪氨酸抗体。2)碳水化合物-凝集素相互作用
CD87和CR3将在现场通过共址研究进行评估
以及缺乏特定的糖类。评估趋化性的研究将是
并行不悖。CR3和CD87的直接相互作用与特异性
CD87的相关结构域将通过转基因的小鼠细胞进行评估
用CR3和可溶性人重组CD87表达。3)PMA和细胞因子诱导
用酶联免疫吸附试验定量检测CD87的脱落及其作用机制
CD87与已知CD87分子量的比较分析
变种。候选机制的特定抑制剂将用于
评估每种受体对激动剂特异性CD87的相对贡献
正在脱落。4)利用uPA缺陷小鼠,我们将确定uPA是否发挥作用
在单核巨噬细胞体外趋化或白细胞趋化中的作用
在体内对肺部新生芽孢杆菌感染的反应。
这些研究将阐明CD87依赖的分子机制。
单核巨噬细胞趋化作用。通过这种知识,具体地
可以开发治疗性干预措施来控制和调节
炎症反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARGARET R GYETKO其他文献
MARGARET R GYETKO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARGARET R GYETKO', 18)}}的其他基金
THE ROLE OF UROKINASE IN LUNG T LYMPHOCYTE RESPONSES
尿激酶在肺 T 淋巴细胞反应中的作用
- 批准号:
6351533 - 财政年份:2000
- 资助金额:
$ 21.07万 - 项目类别:
THE ROLE OF UROKINASE IN LUNG T LYMPHOCYTE RESPONSES
尿激酶在肺 T 淋巴细胞反应中的作用
- 批准号:
6045022 - 财政年份:2000
- 资助金额:
$ 21.07万 - 项目类别:
THE ROLE OF UROKINASE IN LUNG T LYMPHOCYTE RESPONSES
尿激酶在肺 T 淋巴细胞反应中的作用
- 批准号:
6629002 - 财政年份:2000
- 资助金额:
$ 21.07万 - 项目类别:
THE ROLE OF UROKINASE IN LUNG T LYMPHOCYTE RESPONSES
尿激酶在肺 T 淋巴细胞反应中的作用
- 批准号:
6498967 - 财政年份:2000
- 资助金额:
$ 21.07万 - 项目类别:
相似海外基金
Analysis of expression of Cd antigens in retinoblastoma, and its application for disease classification and therapeutic strategy
视网膜母细胞瘤中Cd抗原的表达分析及其在疾病分类和治疗策略中的应用
- 批准号:
25670726 - 财政年份:2013
- 资助金额:
$ 21.07万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research